Nutlin-3 promotes HBV replication by activating mTOR-mediated autophagy
BackgroundCurrently, there are approximately 240 million individuals worldwide suffering from chronic hepatitis B infection, yet a definitive cure remains elusive. In the context of pharmaceutical interventions for this patient population, the potential issue of Hepatitis B virus (HBV) reactivation...
| Autori principali: | , , , |
|---|---|
| Natura: | Articolo |
| Lingua: | English |
| Pubblicazione: |
Frontiers Media S.A.
2024-11-01
|
| Serie: | Acta Virologica |
| Soggetti: | |
| Accesso online: | https://www.frontierspartnerships.org/articles/10.3389/av.2024.12585/full |